US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history.
Posted on 23 November 2015
US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history.
Posted on 28 April 2015
Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel
Posted on 22 April 2015
Teva Pharmaceutical announced a proposal to acquire all of the outstanding shares of Mylan in a transaction valued at $40 billion
Posted on 14 April 2015
Roche has acquired CAPP Medical, a genomics research company
Posted on 13 April 2015
Mylan has made a proposal to acquire Perrigo in a cash-and-stock transaction that would create a diversified, global pharmaceutical leader
Posted on 01 April 2015
Horizon Pharma will acquire all of the issued and outstanding shares of Hyperion’s common stock for $46.00 per share in cash or approximately $1.1 billion
Posted on 01 April 2015
OptumRx and Catamaran have agreed to combine
Posted on 31 March 2015
Teva and Auspex Pharmaceuticals have entered into a definitive merger agreement
Posted on 25 March 2015
Mumbai, India: March 25, 2015 – Sun Pharmaceutical Industries Ltd., begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.
Posted on 23 March 2015
Janssen Pharmaceuticals has acquired XO1 Limited